A clinical study of MK-4646 in people with HIV (MK-4646-003)

2025-521102-17-00 Protocol MK-4646-003 Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 31 Jul 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol MK-4646-003

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 28
Countries 1
Sites 1

HIV infection

Key facts

Sponsor
Merck Sharp & Dohme LLC
Participant type
Patients
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Virus Diseases [C02]
Trial duration
31 Jul 2025 → ongoing
Decision date (initial)
2025-07-25
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

External identifiers

EU CT number
2025-521102-17-00
WHO UTN
U1111-1318-7985

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

HIV infection

VersionLevelCodeTermSystem organ class
20.1 PT 10020161 HIV infection 100000004862

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Merck Sharp & Dohme LLC

Sponsor organisation
Merck Sharp & Dohme LLC
Address
126 East Lincoln Avenue, P. O. Box 2000 P. O. Box 2000
City
Rahway
Postcode
07065-4607
Country
United States

Scientific contact point

Organisation
Merck Sharp & Dohme LLC
Contact name
Russ Carstens

Public contact point

Organisation
Merck Sharp & Dohme LLC
Contact name
Russ Carstens

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Romania Ongoing, recruiting 14 1
Rest of world
Moldova, Republic of
14

Investigational sites

Romania

1 site · Ongoing, recruiting
Institutul National De Boli Infectioase Prof.Dr.Matei Bals
Institutul National De Boli Infectioase Prof.Dr.Matei Bals ‘Phase I Unit: Pavilion 1, Wards 2,3,4', Strada Dr. Calistrat Grozovici Nr. 1, 021105, Bucharest

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Romania 2025-07-31 2025-08-05

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-04-04 Romania No conclusion
2025-07-21
2025-07-25
2 NON SUBSTANTIAL MODIFICATION NSM-1 2025-09-02 Romania No conclusion
2025-07-21
2025-09-02